FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marco Siccardi

Research Profile

Disorders

HIV Infections

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Antonio D'Avolio; Giovanni Di Perri; Giovanna Larovere; Mauro Sciandra; Marco Siccardi; Marco Simiele; Mariacristina Tettoni; Laura Trentini; Silvia Agati; Lorena Baietto; Andrea Calcagno; Jessica Cusato; Stefano Bonora
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.
Marco Siccardi; Steve Rannard; Marco Giardiello; Neill J Liptrott; Philip Martin; Tom O McDonald; Andrew Owen
Nanomedicines for HIV therapy.
Antonio D'Avolio; Diego Aguilar Marucco; Daniel Gonzalez de Requena; Mario Rizzetto; Mauro Sciandra; Marco Siccardi; Marco Simiele; Antonina Smedile; Giulia Troshina; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Giuseppe Cariti; Gian Paolo Caviglia; Alessia Ciancio; Jessica Cusato; Giovanni Di Perri
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marco Siccardi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Antonio D'Avolio; Giovanni Di Perri; Giovanna Larovere; Mauro Sciandra; Marco Siccardi; Marco Simiele; Mariacristina Tettoni; Laura Trentini; Silvia Agati; Lorena Baietto; Andrea Calcagno; Jessica Cusato; Stefano Bonora
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.
The Journal of antimicrobial chemotherapy 2013;68(4):907-10.
2013: Marco Siccardi; Steve Rannard; Marco Giardiello; Neill J Liptrott; Philip Martin; Tom O McDonald; Andrew Owen
Nanomedicines for HIV therapy.
Therapeutic delivery 2013;4(2):153-6.
2012: Antonio D'Avolio; Diego Aguilar Marucco; Daniel Gonzalez de Requena; Mario Rizzetto; Mauro Sciandra; Marco Siccardi; Marco Simiele; Antonina Smedile; Giulia Troshina; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Giuseppe Cariti; Gian Paolo Caviglia; Alessia Ciancio; Jessica Cusato; Giovanni Di Perri
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.
Therapeutic drug monitoring 2012;34(6):722-8.
2012: Lorena Baietto; Eleonora Biasin; Francesca Carraro; Jessica Cusato; Antonio Dʼavolio; Francesco G De Rosa; Cristina Marra; Francesca Nesi; Simone Pace; Marco Siccardi; Marco Simiele; Giovanni Di Perri
Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population.
Therapeutic drug monitoring 2012;34(5):604-6.
2012: Marco Siccardi; Christoph Wyen; Lisa M Almond; Marta Boffito; N H Brockmeyer; Chantal Csajka; Catia Marzolini; A Owen; A Schipani; D Back
Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model.
Clinical pharmacology and therapeutics 2012;92(4):494-502.
2012: Andrea Calcagno; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Letizia Marinaro; Marco Siccardi; Marco Simiele; Aylin Yilmaz; Roberto Bertucci; Stefano Bonora
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.
AIDS (London, England) 2012;26(12):1529-33.
2012: Andrea Calcagno; Jessica Cusato; Antonio D'Avolio; Valentina Libanore; Roberto Rostagno; Marco Siccardi; Marco Simiele; Lorena Baietto; Stefano Bonora; Giovanni Di Perri
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
British journal of clinical pharmacology 2012;74(1):134-40.
2012: Darren M Moss; Matthew Murphy; David J Back; Saye H Khoo; Michael M Piperakis; Marco Siccardi; Andrew Owen
Divalent metals and pH alter raltegravir disposition in vitro.
Antimicrobial agents and chemotherapy 2012;56(6):3020-6.
2012: Antonio DʼAvolio; Daniel Gonzalez de Requena; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Giuseppe Cariti; Alessia Ciancio; Jessica Cusato; Diego Aguilar Marucco; Mario Rizzetto; Mauro Sciandra; Marco Siccardi; Marco Simiele; Antonina Smedile; Giulia Troshina; Giovanni Di Perri
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment.
Therapeutic drug monitoring 2012;34(2):165-70.
2012: Marco Siccardi; Marco Simiele; Vicente Soriano; Darren Moss; Andrew Owen; Sonia Rodriguez-Novoa; David J Back; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Lorena Cuenca; Antonio DʼAvolio; Giovanni Di Perri
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting.
Therapeutic drug monitoring 2012;34(2):232-5.
2012: Mirjam de Roche; Françoise Livio; David Back; Manuel Battegay; Marco Siccardi; Marcel Stoeckle; Catia Marzolini
Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosing.
Antiviral therapy 2012;17(7):1381-4.
2012: Neill J Liptrott; Stefan Mauss; Andrew Owen; Munir Pirmohamed; Sudeep Pushpakom; Marco Siccardi; Christoph Wyen; David J Back; Norbert H Brockmeyer; Gerd Fätkenheuer; Christian Hoffmann; Elizabeth Hopper-Borge; Saye H Khoo; Heribert Knechten
Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS.
Pharmacogenetics and genomics 2012;22(1):10-9.
2011: Antonio D'Avolio; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Giuseppe Cariti; Alessia Ciancio; Jessica Cusato; Mario Rizzetto; Marco Siccardi; Marco Simiele; Antonina Smedile; Giovanni Di Perri
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.
Hepatology (Baltimore, Md.) 2011;54(6):2278-9.
2011: Christoph Wyen; David J Back; Bernhard Bieniek; Johannes R Bogner; Norbert H Brockmeyer; Verena Dlugay; Deirdre Egan; Stefan Esser; Gerd Fätkenheuer; Thomas Harrer; Heidy Hendra; Christian Hoffmann; Hans Jaeger; Alexander Jetter; Hartwig Klinker; Heribert Knechten; Claudia Michalik; Andrew Owen; Martin Platten; Jürgen Rockstroh; Marco Siccardi; Adriane Skaletz-Rorowski; Albrecht Stoehr
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
The Journal of antimicrobial chemotherapy 2011;66(9):2092-8.
2011: Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Francesco Giuseppe De Rosa; Giovanni Di Perri
Ceftriaxone bone penetration in patients with septic non-union of the tibia.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2011;15(6):e415-21.
2011: Alessandro Schipani; Marco Siccardi; Christoph Wyen; Michael Youle; David J Back; Norbert H Brockmeyer; Gerry Davies; Deirdre Egan; Gerd Fätkenheuer; Heidy Hendra; Margaret A Johnson; Saye Khoo; Tabitha Mahungu; Andrew Owen; Jürgen Rockstroh
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.
The Journal of antimicrobial chemotherapy 2011;66(6):1332-9.
2011: Marco Simiele; Antonio D'Avolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Silvia Agati; Jessica Cusato; Stefano Bonora; Giovanni Di Perri
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.
Antimicrobial agents and chemotherapy 2011;55(6):2976-8.
2011: Antonio D'Avolio; Marco Simiele; Marco Siccardi; Lorena Baietto; Mauro Sciandra; Valentina Oddone; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Stefano Bonora; Giovanni Di Perri
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
Journal of pharmaceutical and biomedical analysis 2011;54(4):779-88.
2011: Darren M Moss; Wai San Kwan; Neill Liptrott; Darren L Smith; Marco Siccardi; Saye H Khoo; David J Back; Andrew Owen
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir.
Antimicrobial agents and chemotherapy 2011;55(2):879-87.
2011: Stefano Bonora; Andrea Calcagno; Antonio D'Avolio; Daniel Gonzalez de Requena; Marco Siccardi; Marco Simiele; Mariacristina Tettoni; Laura Trentini; Lorena Baietto; Giovanni Di Perri
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Antiviral therapy 2011;16(4):499-504.
2010: Marco Siccardi; Antonio D'Avolio; Silvia Nozza; Marco Simiele; Lorena Baietto; Francesca Romana Stefani; Darren Moss; Wai-San Kwan; Antonella Castagna; Adriano Lazzarin; Andrea Calcagno; Stefano Bonora; David Back; Giovanni Di Perri; Andrew Owen
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism.
Pharmacogenetics and genomics 2010;20(12):759-65.
2010: Alessandro Schipani; Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Marco Simiele; Stefano Bonora; Sonia Rodríguez-Novoa; Lorena Cuenca; Vincent Soriano; Nitipatana Chierakul; Natpratou Saguenwong; Charoen Chuchuttaworn; Janelle M Hoskins; Anne M Dvorak; Howard L McLeod; Gerry Davies; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance.
Antimicrobial agents and chemotherapy 2010;54(12):5242-50.
2010: Antonio D'Avolio; Marco Simiele; Marco Siccardi; Lorena Baietto; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
Journal of pharmaceutical and biomedical analysis 2010;52(5):774-80.
2010: Lorena Baietto; Antonio D'Avolio; Giusi Ventimiglia; Francesco Giuseppe De Rosa; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
Antimicrobial agents and chemotherapy 2010;54(8):3408-13.
2010: Andrea Calcagno; Stefano Bonora; Antonio D'Avolio; Marco Siccardi; Marco Simiele; Mattia Chiesa; Daniel Gonzalez de Requena; Giovanni Di Perri
Raltegravir penetration in seminal plasma of healthy volunteers.
Antimicrobial agents and chemotherapy 2010;54(6):2744-5.
2010: Antonio D'Avolio; Marco Simiele; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Samantha Patanella; Stefano Bonora; Giovanni Di Perri
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.
Therapeutic drug monitoring 2010;32(1):86-92.
2010: Lorena Baietto; Antonio D'Avolio; Francesco Giuseppe De Rosa; Silvia Garazzino; Marianna Michelazzo; Giusi Ventimiglia; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.
Analytical and bioanalytical chemistry 2010;396(2):791-8.
2009: Antonio Di Biagio; Raffaella Rosso; Marco Siccardi; Antonio D'Avolio; Stefano Bonora; Claudio Viscoli
Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.
The Journal of antimicrobial chemotherapy 2009;64(4):874-5.
2009: Silvia De Francia; Antonio D'Avolio; Francesca De Martino; Elisa Pirro; Lorena Baietto; Marco Siccardi; Marco Simiele; Silvia Racca; Giuseppe Saglio; Francesco Di Carlo; Giovanni Di Perri
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(18-19):1721-6.
2009: Lorena Baietto; Antonio D'Avolio; francesco giuseppe de rosa; Silvia Garazzino; Samantha Patanella; Marco Siccardi; Mauro Sciandra; Giovanni Di Perri
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.
Therapeutic drug monitoring 2009;31(1):104-9.
2008: Antonio D'Avolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Marco Simiele; Valentina Oddone; Stefano Bonora; Giovanni Di Perri
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.
Therapeutic drug monitoring 2008;30(6):662-9.
2008: Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Sara Gibbons; Mauro Sciandra; Daniela Colucci; Stefano Bonora; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(9):1222-5.
2008: Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
Journal of chromatographic science 2008;46(6):524-8.
2008: D Aguilar Marucco; D Gonzalez de Requena; Stefano Bonora; C Tettoni; M Bonasso; T De Blasi; Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; L Baietto; Laura Trentini; Alessandro Sinicco; Giuseppe Cariti; Giovanni Di Perri
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
The Journal of antimicrobial chemotherapy 2008;61(4):919-24.
2008: Daniel Gonzalez de Requena; Stefano Bonora; Andrea Calcagno; Antonio D'Avolio; Marco Siccardi; Silvia Fontana; Maria Grazia Milia; Mauro Sciandra; Silvia Garazzino; Antonio Di Garbo; Lorena Baietto; Laura Trentini; Giovanni Di Perri
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.
Antimicrobial agents and chemotherapy 2008;52(3):1066-71.
2008: Antonio D'Avolio; Lorena Baietto; francesco giuseppe de rosa; Silvia Garazzino; Mauro Sciandra; Marco Siccardi; Stefano Bonora; Giovanni Di Perri
A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.
Therapeutic drug monitoring 2008;30(1):90-4.
2008: Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; francesco giuseppe de rosa; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Giovanni Di Perri
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
Clinical pharmacokinetics 2008;47(12):793-805.
2007: Stefano Bonora; Andrea Calcagno; Silvia Fontana; Antonio D'Avolio; Marco Siccardi; Federico Gobbi; Giovanni Di Perri
Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(12):1654-5.
2007: Antonio D'Avolio; Marco Siccardi; Mauro Sciandra; Lorena Baietto; Baietto Lorena; Stefano Bonora; Laura Trentini; Giovanni Di Perri
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;859(2):234-40.
2007: Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;848(2):374-8.
2006: Daniel González de Requena; Andrea Calcagno; Stefano Bonora; Laura Ladetto; Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Olivia Bargiacchi; Alessandro Sinicco; Giovanni Di Perri
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide.
AIDS (London, England) 2006;20(15):1977-9.
2006: Antonio D'Avolio; Allende Ibañez; Mauro Sciandra; Marco Siccardi; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;835(1-2):127-30.